Biopharma facility qualification ensures production environments, utility systems, and equipment meet regulations for new ...
BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION 1. The Secretary of Commerce (Secretary) recently transmitted to me a report on his ...
As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...
Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...
Pharmaceutical regulatory consulting for drug developers and CROs: IND CMC, method validation, NDA strategy, and FDA ...
Orforglipron is the first new molecular entity cleared under the FDA's Commissioner's National Priority Voucher (CNPV) pilot ...
Ghana News Agency on MSN
Lab-on-a-chip technology set to transform drug development, healthcare delivery in Ghana
By James Amoh Jnr, GNA Special Correspondent, London, United KingdomLondon (UK), March 30, GNA – Across laboratories ...
Charles R. Goulding and Andressa Bonafe highlight the shift from clinical pilot programs to everyday pharmacy practice, where ...
Scale-up involves increasing pump sizes, reactor volumes, and flow rates—but the process control logic and system ...
When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that ...
In addition to pulmonary fibrosis treatment Jascayd, the company’s oral drug Hernexeos, which treats HER2-mutant advanced, ...
WASHINGTON, DC / ACCESS Newswire / March 24, 2026 / A new federal initiative allowing up to $500 annually in hemp-derived cannabinoid products for Medicare beneficiaries is raising urgent questions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results